NEW YORK, May 12 - Genedata of Basel, Switzerland, said today that would supply Japan's National Cancer Center with software for a proteomics-based cancer research project.
NCC will use Genedata's Impressionist 2D-protein gel analysis software to identify diagnostic marker proteins to help classify cancer types into subclasses, the company said.
Tadashi Kondo, section head of NCC's biology division, said the project would study "many different cancer samples from clinics as well as from cell lines."
NCC plans to use the software for data quality assessment, data standardization, and biostatistical data analysis.